Daniel Claassen, MD

Development of Deutetrabenazine as a Potential New Non-Antipsychotic Treatment for Tourette Syndrome in Children and Adolescents

Background: Tourette syndrome (TS) is a neurodevelopmental disorder characterized by the hyperkinetic movements of motor and phonic tics manifested in young age. Currently approved treatm...

Joseph Jankovic , MD;

Maria Wieman , MPH;

Barbara Coffey , MD, MS;

David Stamler , MD;

Daniel Claassen , MD;

Barry Gertz , MD, PhD;

Elisabeth Garofalo , MD;

Juha-Matti Savola , MD, PhD;

Mark Forrest Gordon , MD;

11/22/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Daniel Claassen, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products